Filing Details

Accession Number:
0001576885-24-000025
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-01-19 19:05:14
Reporting Period:
2024-01-18
Accepted Time:
2024-01-19 19:05:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1576885 Acumen Pharmaceuticals Inc. ABOS Biological Products, (No Disgnostic Substances) (2836) 364108129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1866239 Eric Siemers C/O Acumen Pharmaceuticals, Inc.
427 Park Street
Charlottesville VA 22902
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-01-18 3,124 $3.71 117,576 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2023.
  2. The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $3.7103 and $3.7150. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.